首页> 外文期刊>BMJ Open Respiratory Research >Description of the protocol for the PRACTICAL study: a randomised controlled trial of the efficacy and safety of ICS/LABA reliever therapy in asthma
【24h】

Description of the protocol for the PRACTICAL study: a randomised controlled trial of the efficacy and safety of ICS/LABA reliever therapy in asthma

机译:实用研究方案的描述:ICS / LABA缓解剂治疗哮喘的疗效和安全性的随机对照试验

获取原文
       

摘要

Abstract Introduction In adult asthma, combination inhaled corticosteroid (ICS)/fast-onset long-acting beta agonist (LABA) used solely as reliever therapy may represent an effective and safe alternative to ICS maintenance and short-acting beta agonist (SA
机译:摘要引言在成人哮喘中,仅将吸入性糖皮质激素(ICS)/速效长效β受体激动剂(LABA)组合用作缓解药物可能是ICS维持和短效β受体激动剂(SA)的一种有效且安全的替代方法

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号